B. Payami, A. Zarrin, M. Hosseinzadeh, H. Haybar, and S. Khodamoradi, “Amiodarone Can Still Be a Drug of Choice at Emergency Departments for Pre-excited Atrial Fibrillation Even in the Face of Guidelines Prohibition”, J Pract Emerg Med, vol. 10, no. 1, p. e8, May 2023.